Table 3.
Linear regression of influence of AST/ALT to BMDs in T2DM.
| Variable | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| Beta (95%CI) | P-value | Beta (95%CI) | P-value | Beta (95%CI) | P-value | |
| FN BMD | −0.423 (−0.310∼−0.218) | <0.001 | −0.194 (−0.167∼−0.037) | <0.001 | −0.189 (−0.162∼−0.074) | <0.001 |
| LH BMD | −0.335 (−0.301∼−0.189) | <0.001 | −0.128 (−0.152∼−0.037) | <0.001 | −0.335 (−0.147∼−0.036) | <0.001 |
| LS BMD | −0.409 (−0.396∼−0.274) | <0.001 | −0.197 (−0.224∼−0.099) | <0.001 | −0.409 (−0.196∼−0.079) | <0.001 |
FN, femoral neck; LH, left hip; LS, lumbar spine.
Model 1 is unadjusted.
Model 2 is adjusted for age, sex, smoking, drinking and BMI.
Model 3 is adjusted for age, sex, smoking, drinking, BMI, SBP, DBP, duration of diabetes, ALT, Cr, UA, OC, β-CTX, PINP and 25(OH)D.
This work is licensed under a